Prerequisites to Implementing a Pharmacogenomics Program in a Large Health-Care System

Pharmacogenomics (PGx) technology is advancing rapidly; however, clinical adoption is lagging. The Indiana Institute of Personalized Medicine (IIPM) places a strong focus on translating PGx research into clinical practice. We describe what have been found to be the key requirements that must be deli...

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	Clinical pharmacology and therapeutics 2014-09, Vol.96 (3), p.307-309
Hauptverfasser:	Levy, K D, Decker, B S, Carpenter, J S, Flockhart, D A, Dexter, P R, Desta, Z, Skaar, T C
Format:	Artikel
Sprache:	eng
Schlagworte:	Cooperative Behavior Delivery of Health Care - organization & administration Diffusion of Innovation Humans Interdisciplinary Communication Organizational Objectives Pharmacogenetics - organization & administration Precision Medicine Program Development Translational Research, Biomedical
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Beschreibung
Zusammenfassung:	Pharmacogenomics (PGx) technology is advancing rapidly; however, clinical adoption is lagging. The Indiana Institute of Personalized Medicine (IIPM) places a strong focus on translating PGx research into clinical practice. We describe what have been found to be the key requirements that must be delivered in order to ensure a successful and enduring PGx implementation within a large health‐care system. Clinical Pharmacology & Therapeutics (2014); 96 3, 307–309. advance online publication 11 June 2014. doi:10.1038/clpt.2014.101
ISSN:	0009-9236 1532-6535
DOI:	10.1038/clpt.2014.101